In AD, tau undergoes aberrant hyperphosphorylation, predominantly mediated by kinases such as glycogen synthase kinase-3β (GSK-3β), cyclin-dependent kinase 5 (Cdk5), and others [36]. Here, MAPT is linked to Alzheimer disease.